Chick-fil-A announced that it would be shifting from antibiotic-free chicken starting this spring, citing supply reasons, in an update shared Thursday.
"To maintain supply of the high-quality chicken you expect from us, Chick-fil-A will shift from No Antibiotics Ever (NAE) to No Antibiotics Important To Human Medicine (NAIHM) starting in the Spring of 2024," the announcement read.
No specific deadline has yet to be announced for the change to roll out.
CHICK-FIL-A ROLLS OUT NUGGET-TOPPED PIZZA PIES AT MARYLAND TEST KITCHEN: 'LOVE BEFORE BITE'
According to the Chick-fil-A website, NAE means no antibiotics of any kind were used in the raising of the animal, while NAIHM "restricts the use of those antibiotics that are important to human medicine and commonly used to treat people, and allows use of animal antibiotics only if the animal and those around it were to become sick."
Chick-fil-A had previously switched to antibiotic-free chicken in 2014, eventually meeting its goal of serving antibiotic-free chicken at all chain restaurants in 2019.
CHICK-FIL-A LAUNCHING MANHATTAN RESTAURANT WITH MOBILE PICKUP AND DELIVERY ONLY
"As we looked to the future, the availability of high-quality chicken that meets our rigid standards became a concern. This change enables us to not only ensure we can continue to serve high-quality chicken, but also chicken that still meets the expectations our customers count on us to deliver," a Chick-fil-A spokesperson told Fox News Digital in a statement.
The announcement was sent to app users as well, according to Reuters.
CHICK-FIL-A RECALLS POPULAR POLYNESIAN SAUCE DIPPING CUPS: 'PLEASE DISCARD'
Panera Bread also recently switched from its antibiotic-free policy in its pork and turkey products, writing that the policy limited its supply chain options, according to documents obtained by Reuters.
Tyson Foods announced last summer that it was also reintroducing certain antibiotics to its chicken supply chain, having previously gone antibiotic-free in 2017.
CLICK HERE TO READ MORE ON FOX BUSINESS
Reuters contributed to this report.
